Capital Market Strategies LLC Acquires 29 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Capital Market Strategies LLC lifted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,826 shares of the biotechnology company’s stock after purchasing an additional 29 shares during the quarter. Axon Enterprise accounts for 1.0% of Capital Market Strategies LLC’s holdings, making the stock its 20th largest position. Capital Market Strategies LLC’s holdings in Axon Enterprise were worth $1,680,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Public Sector Pension Investment Board increased its holdings in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the period. CIBC Asset Management Inc lifted its stake in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $221,000. Sequoia Financial Advisors LLC raised its holdings in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after buying an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth $814,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,545 shares of company stock worth $31,159,317. 6.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on AXON shares. The Goldman Sachs Group lifted their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. JMP Securities upped their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $488.67.

Axon Enterprise Stock Down 6.3 %

Axon Enterprise stock traded down $37.62 during midday trading on Monday, hitting $563.44. 1,007,622 shares of the stock were exchanged, compared to its average volume of 646,014. Axon Enterprise, Inc. has a 52-week low of $244.01 and a 52-week high of $698.67. The business’s 50-day moving average price is $593.68 and its 200-day moving average price is $441.20. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $42.97 billion, a price-to-earnings ratio of 145.59, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.